Cargando…

Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus

Hematological complications in renal transplant recipients include anemia, leukopenia, and post-transplant erythrocytosis (PTE). There are numerous causes for these which include immunosuppressive drugs, viral infections, etc. We report here a hepatitis C (HCV)-positive case who developed PTE while...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, A. A. M., Khanna, P., Mehrotra, A., Abraham, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132334/
https://www.ncbi.nlm.nih.gov/pubmed/21769178
http://dx.doi.org/10.4103/0971-4065.82142
_version_ 1782207804514238464
author Ali, A. A. M.
Khanna, P.
Mehrotra, A.
Abraham, G.
author_facet Ali, A. A. M.
Khanna, P.
Mehrotra, A.
Abraham, G.
author_sort Ali, A. A. M.
collection PubMed
description Hematological complications in renal transplant recipients include anemia, leukopenia, and post-transplant erythrocytosis (PTE). There are numerous causes for these which include immunosuppressive drugs, viral infections, etc. We report here a hepatitis C (HCV)-positive case who developed PTE while receiving rapamycin. As both HCV infection and rapamycin through different mechanisms can produce anemia, this case report highlights the rarity of erythrocytosis.
format Online
Article
Text
id pubmed-3132334
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31323342011-07-18 Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus Ali, A. A. M. Khanna, P. Mehrotra, A. Abraham, G. Indian J Nephrol Case Report Hematological complications in renal transplant recipients include anemia, leukopenia, and post-transplant erythrocytosis (PTE). There are numerous causes for these which include immunosuppressive drugs, viral infections, etc. We report here a hepatitis C (HCV)-positive case who developed PTE while receiving rapamycin. As both HCV infection and rapamycin through different mechanisms can produce anemia, this case report highlights the rarity of erythrocytosis. Medknow Publications 2011 /pmc/articles/PMC3132334/ /pubmed/21769178 http://dx.doi.org/10.4103/0971-4065.82142 Text en Copyright: © Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ali, A. A. M.
Khanna, P.
Mehrotra, A.
Abraham, G.
Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
title Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
title_full Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
title_fullStr Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
title_full_unstemmed Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
title_short Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
title_sort late post-transplant erythrocytosis in a hepatitis c-positive allograft recipient on sirolimus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132334/
https://www.ncbi.nlm.nih.gov/pubmed/21769178
http://dx.doi.org/10.4103/0971-4065.82142
work_keys_str_mv AT aliaam lateposttransplanterythrocytosisinahepatitiscpositiveallograftrecipientonsirolimus
AT khannap lateposttransplanterythrocytosisinahepatitiscpositiveallograftrecipientonsirolimus
AT mehrotraa lateposttransplanterythrocytosisinahepatitiscpositiveallograftrecipientonsirolimus
AT abrahamg lateposttransplanterythrocytosisinahepatitiscpositiveallograftrecipientonsirolimus